Abstract
UP-2.148: Three Months Intermittent Hormone Therapy +/- 5 Alpha Reductase as an Alternate to Active Monitoring To Separate Latent from Clinically Significant Prostate Cancer
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have